← Eichor
Study identifier: NCT07088536 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Occupational Situation and Return to Work of Urological Patients

Condition: Bladder Cancer · Prostate Cancer · Renal Cancer  ·  Sponsor: Jagiellonian University

PhaseN/A
Planned participants2000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will examine the work status of all adult patients admitted over a 6-month period to the University Hospital in Kraków, Poland, for treatment of urological diseases. All admitted patients will be surveyed about their job situation. Patients who are occupationally active and undergoing major oncological surgeries (such as radical cystectomy, prostatectomy, or nephrectomy) or procedures for urinary tract stones will also complete a quality-of-life questionnaire and be followed up by phone at 3 and 6 months. The goal is to learn how treatment affects patients' ability to return to work and their well-being, to help guide support and rehabilitation strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Anna K. Czech, M.D., Ph.D.  ·  +48124002500  ·  aka.czech@uj.edu.pl

Jakub Frydrych, M.D.  ·  +48124002500  ·  frydrych.jf@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Jagiellonian University Medical CollegeKrakow, Malopolska, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07088536